任凌彤,艾虎

• 1:北京医院心内科国家老年医学中心中国医学科学院老年医学研究院
• 2:北京大学医学部第五临床医学院

摘要(Abstract)：

随着对冠状动脉相关疾病研究的深入，人们逐渐认识到冠状动脉微循环障碍对于心血管疾病的发生、发展、疗效及预后等具有重要影响，冠状动脉微循环疾病在缺血性心脏病中受到越来越多的重视。由于无法直接通过影像学观察到冠状动脉微血管，目前临床上出现了一些评价冠状动脉微循环功能的指标，其中微循环阻力指数被广泛用于冠状动脉微循环功能评价。基于计算流体力学的微循环阻力指数测定技术准确、安全、简单易行，应用前景广泛。本文就微循环阻力指数的建立、发展、临床应用、进展进行综述。

关键词(KeyWords)： 微循环阻力指数;冠状动脉微循环功能障碍;计算流体力学

Abstract:

Keywords:

基金项目(Foundation): 中国医学科学院医学与健康科技创新工程项目（2021-I2M-C&T-A-019）;; 首都临床诊疗技术研究及转化应用项目（Z211100002921008）;; 中央高水平医院临床科研业务费资助项目（BJ-2019-193）

作者(Author): 任凌彤,艾虎

参考文献(References)：

• [1] Fearon WF,Balsam LB,Farouque HM,et al. Novel index for invasively assessing the coronary microcirculation:[J].Circulation,2003,107(25):3129-3132. DOI:10.1161/01.CIR.0000080700.98607.D1.
• [2] Aarnoudse W,Fearon WF,Manoharan G,et al. Epicardial stenosis severity does not affect minimal microcirculatory resistance[J]. Circulation,2004,110(15):2137-2142.DOI:10.1161/01.CIR.0000143893.18451.0E.
• [3] Yong AS,Layland J,Fearon WF,et al. Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis[J]. JACC Cardiovasc Interv,2013,6(1):53-58. DOI:10.1016/j.jcin.2012.08.019.
• [4] M elikian N,Vercauteren S,Fearon WF,et al. Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis[J]. EuroIntervention,2010,5(8):939-945.
• [5] Luo C,Long M,Hu X,et al. Thermodilution-derived coronary microvascular resistance and fl ow reserve in patients with cardiac syndrome X[J]. Circ Cardiovasc Interv,2014,7(1):43-48. DOI:10.1161/CIRCINTERVENTIONS.113.000953.
• [6] Lee JM,Layland J,Jung JH,et al. Integrated physiologic assessment of ischemic heart disease in real-world practice using index of microcirculatory resistance and fractional flow reserve:insights from the International Index of Microcirculatory Resistance Registry[J]. Circ Cardiovasc Interv,2015,8(11):e002857.DOI:10.1161/CIRCINTERVENTIONS.115.002857.
• [7] Kunadian V,Chief fo A,Camici PG,et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology&Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group[J]. Eur Heart J,2020,41(37):3504-3520. DOI:10.1093/eurheartj/ehaa503.
• [8]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.缺血伴非阻塞性冠状动脉疾病诊断及管理中国专家共识[J].中华心血管病杂志，2022,50(12):1148-1160. DOI:10.3760/cma.j.cn112148-20220908-00682.
• [9] Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477. DOI:10.1093/eurheartj/ehz425.
• [10]王岚，马玉良，王伟民，等.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后冠状动脉微循环障碍及其对心功能影响的研究[J].中国介入心脏病学杂，2022,30(1):33-37.DOI:10.3969/j.issn.1004-8812.2022.01.006.
• [11] Fearon WF,Low AF,Yong AS,et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention[J]. Circulation,2013,127(24):2436-2441.DOI:10.1161/CIRCULATIONAHA.112.000298.
• [12] Bulluck H,Foin N,Cabrera-Fuentes HA,et al. Index of microvascular resistance and microvascular obstruction in patients with acute myocardial infarction[J]. JACC Cardiovasc Interv,2016,9(20):2172-2174.DOI:10.1016/j.jcin.2016.08.018.
• [13] Carrick D,Haig C,Ahmed N,et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute st-segment-elevation myocardial infarction[J]. Circulation,2016,134(23):1833-1847. DOI:10.1161/CIRCULATIONAHA.116.022603.
• [14] De Maria GL,Alkhalil M,Wolfrum M,et al. Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI[J]. JACC Cardiovasc Imaging,2019,12(5):837-848.DOI:10.1016/j.jcmg.2018.02.018.
• [15] Nishi T,Murai T,Ciccarelli G,et al. Prognostic value of coronary microvascular function measured immediately after percutaneous coronary intervention in stable coronary artery disease:an international multicenter study[J]. Circ Cardiovasc Interv,2019,12(9):e007889. DOI:10.1161/CIRCINTERVENTIONS.119.007889.
• [16] Mangiacapra F,Bressi E,Di Gioia G,et al. Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention[J]. Int J Cardiol,2020,306:42-46. DOI:10.1016/j.ijcard.2019.12.042.
• [17] Lee JM,Jung JH,Hwang D,et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis[J]. J Am Coll Cardiol,2016,67(10):1158-1169. DOI:10.1016/j.jacc.2015.12.053.
• [18] Layland J,Whitbourn R,Macisaac A,et al. Takotsubo cardiomyopathy:reversible elevation in microcirculatory resistance[J]. Cardiovasc Revasc Med,2012,13(1):66-68. DOI:10.1016/j.carrev.2011.06.005.
• [19] Cuisset T,Quilici J,Pankert M,et al. Usefulness of index of microcirculatory resistance to detect microvascular dysfunction as a potential mechanism of stress-induced cardiomyopathy(Takotsubo syndrome)[J]. Int J Cardiol,2011,153(3):e51-e53. DOI:10.1016/j.ijcard.2011.02.028.
• [20] Daniels DV,Fearon WF. The index of microcirculatory resistance(IMR)in takotsubo cardiomyopathy[J]. Catheter Cardiovasc Interv,2011,77(1):128-131. DOI:10.1002/ccd.22599.
• [21] Montone RA,Galiuto L,Meucci MC,et al. Coronary slow fl ow is associated with a worse clinical outcome in patients with Takotsubo syndrome[J]. Heart,2020,106(12):923-930.DOI:10.1136/heartjnl-2019-315909.
• [22] Gutiérrez-Barrios A,Camacho-Jurado F,Díaz-Retamino E,et al. Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy:the index of microvascular resistance[J]. Cardiovasc Revasc Med,2015,16(7):426-428. DOI:10.1016/j.carrev.2015.06.008.
• [23] Aguiar Rosa S,Mota Carmo M,Rocha Lopes L,et al. Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy[J]. Rev Port Cardiol,2022,41(9):761-767. DOI:10.1016/j.repc.2021.07.013.
• [24]杨国建，孙福成.无创CT血流储备分数的研究进展[J].中国心血管杂志，2019,24(4):387-391.DOI:10.3969/j.issn.1007-5410.2019.04.019.
• [25]李乐，艾虎，孙福成.冠状动脉血流储备分数衍生指标进展[J].中华心血管病杂志，2021,49(11):1157-1162.DOI:10.3760/cma.j.cn112148-20210911-00782.
• [26] Ai H,Feng Y,Gong Y,et al. Coronary angiography-derived index of microvascular resistance[J]. Front Physiol,2020,11:605356.DOI:10.3389/fphys.2020.605356.
• [27] Huang D,Gong Y,Fan Y,et al. Coronary angiographyderived index for assessing microcirculatory resistance in patients with non-obstructed vessels:The FLASH IMR study[J]. Am Heart J,2023,263:56-63. DOI:10.1016/j.ahj.2023.03.016.
• [28] Choi KH,Dai N,Li Y,et al. Functional coronary angiographyderived index of microcirculatory resistance in patients with STsegment elevation myocardial infarction[J]. JACC Cardiovasc Interv,2021,14(15):1670-1684.DOI:10.1016/j.jcin.2021.05.027.
• [29] Shin D,Kim J,Choi KH,et al. Functional angiography-derived index of microcirculatory resistance validated with microvascular obstruction in cardiac magnetic resonance after STEMI[J]. Rev Esp Cardiol(Engl Ed),2022,75(10):786-796. DOI:10.1016/j.rec.2022.01.004.
• [30] Li H,Peng X,Li L, et al. Coronary microcirculatory function indicated by coronary angiography-derived index of microvascular resistance in patients undergoing rotational atherectomy[J]. Rev Cardiovasc Med,2022,23(10):330. DOI:10.31083/j.rcm2310330.
• [31] Dai N,Che W,Liu L,et al. Diagnostic value of angiographyderived IMR for coronary microcirculation and its prognostic implication after PCI[J]. Front Cardiovasc Med,2021,8:735743. DOI:10.3389/fcvm.2021.735743.
• [32] Li M,Su H,Zuo Z,et al. The role of the angiography-derived index of microcirculatory resistance in the prognosis of patients with dilated cardiomyopathy[J]. Quant Imaging Med Surg,2023,13(4):2647-2659. DOI:10.21037/qims-22-1060.
• [33] Wang X,Guo Q,Guo R,et al. Coronary angiography-derived index of microcirculatory resistance and evolution of infarct pathology after STEMI[J][published online ahead of print,2023 Jun 15]. Eur Heart J Cardiovasc Imaging,2023,24(12):1640-1652. DOI:10.1093/ehjci/jead141.
• [34] Mohammed AQ,Abdu FA,Su Y,et al. Prognostic significance of coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction[J]. Can J Cardiol,2023,39(7):971-980. DOI:10.1016/j.cjca.2023.04.011.
• [35]郑文，黄鑫，赵雪东.基于冠状动脉造影测定微循环阻力指数的研究进展[J].中国介入心脏病学杂志，2022,30(6):448-451. DOI:10.3969/j.issn.1004-8812.2022.06.011.
• [36] Scarsini R,Shanmuganathan M,Kotronias RA,et al.Angiography-derived index of microcirculatory resistance(IMRangio)as a novel pressure-wire-free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease[J]. Int J Cardiovasc Imaging,2021,37(6):1801-1813. DOI:10.1007/s10554-021-02254-8.
• [37] Sans-RosellóJ,Fernández-Peregrina E,Duran-Cambra A,et al. Coronary microvascular dysfunction in Takotsubo syndrome assessed by angiography-derived index of microcirculatory resistance:a pressure-wire-free tool[J]. J Clin Med,2021,10(19):4331. DOI:10.3390/jcm10194331.
• [38] Fan Y,Fezzi S,Sun P,et al. In vivo validation of a novel computational approach to assess microcirculatory resistance based on a single angiographic view[J]. J Pers Med,2022,12(11):1798. DOI:10.3390/jpm12111798.